Bernadette Vertogen

479 total citations
13 papers, 181 citations indexed

About

Bernadette Vertogen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bernadette Vertogen has authored 13 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bernadette Vertogen's work include Cancer Treatment and Pharmacology (4 papers), Neutropenia and Cancer Infections (4 papers) and Colorectal Cancer Treatments and Studies (2 papers). Bernadette Vertogen is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Neutropenia and Cancer Infections (4 papers) and Colorectal Cancer Treatments and Studies (2 papers). Bernadette Vertogen collaborates with scholars based in Italy, United Kingdom and United States. Bernadette Vertogen's co-authors include M. Marangolo, Claudio Dazzi, Maurizio Leoni, Anna Cariello, Emanuela Scarpi, Giovanni Luca Frassineti, Oriana Nanni, A. Tienghi, D. Turci and Manlio Monti and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Frontiers in Pharmacology.

In The Last Decade

Bernadette Vertogen

13 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernadette Vertogen Italy 8 108 78 43 27 24 13 181
Lalit Mohan Sharma India 8 33 0.3× 58 0.7× 40 0.9× 13 0.5× 21 0.9× 28 145
Maryann Napoli United States 5 88 0.8× 144 1.8× 32 0.7× 7 0.3× 10 0.4× 10 197
Nandini Menon India 9 107 1.0× 102 1.3× 48 1.1× 36 1.3× 2 0.1× 46 238
Tomonori Moritaka Japan 11 179 1.7× 218 2.8× 10 0.2× 55 2.0× 5 0.2× 29 325
Jasna But-Hadžić Slovenia 10 137 1.3× 52 0.7× 25 0.6× 15 0.6× 3 0.1× 18 214
Josiane Mourão Dias Brazil 7 86 0.8× 99 1.3× 20 0.5× 38 1.4× 3 0.1× 19 205
Chao-Feng Li China 6 44 0.4× 89 1.1× 13 0.3× 31 1.1× 9 0.4× 6 161
Bao‐Wen Tian China 8 107 1.0× 45 0.6× 5 0.1× 35 1.3× 4 0.2× 23 212
L Solaini Italy 9 38 0.4× 227 2.9× 9 0.2× 23 0.9× 17 0.7× 15 288
Şener Cihan Türkiye 10 145 1.3× 66 0.8× 6 0.1× 29 1.1× 3 0.1× 40 247

Countries citing papers authored by Bernadette Vertogen

Since Specialization
Citations

This map shows the geographic impact of Bernadette Vertogen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernadette Vertogen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernadette Vertogen more than expected).

Fields of papers citing papers by Bernadette Vertogen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernadette Vertogen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernadette Vertogen. The network helps show where Bernadette Vertogen may publish in the future.

Co-authorship network of co-authors of Bernadette Vertogen

This figure shows the co-authorship network connecting the top 25 collaborators of Bernadette Vertogen. A scholar is included among the top collaborators of Bernadette Vertogen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernadette Vertogen. Bernadette Vertogen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Fabbri, Francesca, Patrizia Serra, Bernadette Vertogen, et al.. (2020). How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool. JCO Oncology Practice. 17(1). e68–e76. 7 indexed citations
3.
Monti, Manuela, Bernadette Vertogen, Carla Masini, et al.. (2020). Hydroxychloroquine as Prophylaxis for COVID-19: A Review. Frontiers in Pharmacology. 11. 605185–605185. 7 indexed citations
4.
Casadei‐Gardini, Andrea, Emanuela Scarpi, Martina Valgiusti, et al.. (2020). Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial. Therapeutic Advances in Medical Oncology. 12. 22 indexed citations
5.
Montroni, Isacco, Giampaolo Ugolini, Antonino Spinelli, et al.. (2019). Outcomes that matter to patients: The Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery (GOSAFE) study—Analysis of 471 patients.. Journal of Clinical Oncology. 37(15_suppl). 11511–11511. 5 indexed citations
6.
Ulivi, Paola, Emanuela Scarpi, Alessandro Passardi, et al.. (2015). eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial. Journal of Translational Medicine. 13(1). 258–258. 31 indexed citations
7.
Passardi, Alessandro, Emanuela Scarpi, Luigi Cavanna, et al.. (2013). Effectiveness of bevacizumab added to gold standard chemotherapy in metastatic colorectal cancer (mCRC): Final results from the Itaca randomized clinical trial.. Journal of Clinical Oncology. 31(15_suppl). 3517–3517. 7 indexed citations
8.
Dazzi, Claudio, Anna Cariello, Cláudia Casanova, et al.. (2012). Gemcitabine and Paclitaxel Combination as Second-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Phase II Study. Clinical Lung Cancer. 14(1). 28–33. 12 indexed citations
9.
Ibrahim, Toni, Patrizia Serra, Bernadette Vertogen, M. Marangolo, & D. Amadori. (2007). Doxorubicin (Dox), cyclophosphamide (Cyc) and weekly docetaxel (Doc) as first-line treatment of advanced breast cancer (ABC). Journal of Clinical Oncology. 25(18_suppl). 11516–11516. 1 indexed citations
10.
Giorgi, Ugo De, Bernadette Vertogen, Giuseppe Monti, et al.. (2006). A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization. Bone Marrow Transplantation. 38(6). 407–412. 28 indexed citations
11.
Marangolo, M. & Bernadette Vertogen. (2006). Pemetrexed and malignant pleural mesothelioma. Annals of Oncology. 17. v103–v105. 5 indexed citations
12.
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lalit Mohan Sharma Breakdown of academic impact, for papers by Maryann Napoli Breakdown of academic impact, for papers by Nandini Menon Breakdown of academic impact, for papers by Tomonori Moritaka Breakdown of academic impact, for papers by Jasna But-Hadžić Breakdown of academic impact, for papers by Josiane Mourão Dias Breakdown of academic impact, for papers by Chao-Feng Li Breakdown of academic impact, for papers by Bao‐Wen Tian Breakdown of academic impact, for papers by L Solaini Breakdown of academic impact, for papers by Şener Cihan
Rankless by CCL
2026